Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025
Harrow (NASDAQ:HROW), a leading North American eyecare pharmaceutical company, has scheduled its second quarter 2025 financial results announcement for August 11, 2025, after market close.
The company will release its quarterly Letter to Stockholders on its website and host a conference call with a live webcast on August 12, 2025, at 8:00 a.m. Eastern Time. Investors can access the webcast through Harrow's website, and telephone participants must register in advance to receive dial-in details.
Harrow (NASDAQ:HROW), una delle principali aziende farmaceutiche nordamericane nel settore dell'assistenza oculare, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 11 agosto 2025, dopo la chiusura dei mercati.
L'azienda pubblicherà la sua lettera trimestrale agli azionisti sul proprio sito web e terrà una conference call con webcast in diretta il 12 agosto 2025 alle 8:00 ora della costa orientale. Gli investitori potranno seguire il webcast tramite il sito di Harrow, mentre i partecipanti telefonici devono registrarsi in anticipo per ricevere i dettagli per la chiamata.
Harrow (NASDAQ:HROW), una destacada empresa farmacéutica norteamericana especializada en cuidado ocular, ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el 11 de agosto de 2025, tras el cierre del mercado.
La compañía publicará su carta trimestral a los accionistas en su sitio web y realizará una conferencia telefónica con transmisión en vivo el 12 de agosto de 2025 a las 8:00 a.m., hora del Este. Los inversores podrán acceder a la transmisión a través del sitio web de Harrow, y los participantes telefónicos deben registrarse previamente para recibir los detalles de acceso.
Harrow (NASDAQ:HROW)는 북미를 대표하는 안과용 의약품 회사로, 2025년 2분기 재무 결과 발표를 2025년 8월 11일 장 마감 후에 예정하고 있습니다.
회사는 분기별 주주 서한을 자사 웹사이트에 공개하며, 2025년 8월 12일 오전 8시(동부 시간)에 실시간 웹캐스트가 포함된 컨퍼런스 콜을 진행할 예정입니다. 투자자들은 Harrow 웹사이트를 통해 웹캐스트에 접속할 수 있으며, 전화 참여자는 사전에 등록하여 전화 접속 정보를 받아야 합니다.
Harrow (NASDAQ:HROW), une entreprise pharmaceutique nord-américaine de premier plan dans le domaine des soins oculaires, a programmé l'annonce de ses résultats financiers du deuxième trimestre 2025 pour le 11 août 2025, après la clôture du marché.
La société publiera sa lettre trimestrielle aux actionnaires sur son site web et organisera une conférence téléphonique avec diffusion en direct le 12 août 2025 à 8h00, heure de l'Est. Les investisseurs pourront accéder au webcast via le site de Harrow, et les participants téléphoniques doivent s'inscrire à l'avance pour recevoir les informations d'accès.
Harrow (NASDAQ:HROW), ein führendes nordamerikanisches Pharmaunternehmen im Bereich Augenheilkunde, hat die Bekanntgabe der Finanzergebnisse für das zweite Quartal 2025 für den 11. August 2025 nach Börsenschluss geplant.
Das Unternehmen wird seinen quartalsweisen Brief an die Aktionäre auf seiner Webseite veröffentlichen und am 12. August 2025 um 8:00 Uhr Eastern Time eine Telefonkonferenz mit Live-Webcast abhalten. Investoren können den Webcast über die Harrow-Webseite verfolgen, Telefonteilnehmer müssen sich im Voraus registrieren, um Einwahldaten zu erhalten.
- None.
- None.
Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on August 12, 2025
NASHVILLE, Tenn., July 29, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its financial results for the second quarter ended June 30, 2025, on Monday, August 11, 2025, after the market close. The Company will also post its second quarter Letter to Stockholders to the “Investors” section of its website, harrow.com. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Tuesday, August 12, 2025, to discuss the results and provide a business update.
Conference Call Information
Participants can access the live webcast of Harrow’s presentation on the “Investors” page of Harrow’s website. A replay of the webcast will be available on the Company’s website for one year.
To participate via telephone, please register in advance using this link. Upon registration, all telephone participants will receive a confirmation email with detailed instructions, including a unique dial-in number and PIN, for accessing the call.
About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.
Contact:
Mike Biega
VP of Investor Relations & Communications
mbiega@harrowinc.com
617-913-8890
FAQ
When will Harrow (HROW) report Q2 2025 earnings?
How can investors access Harrow's Q2 2025 earnings call?
Where can I find Harrow's Q2 2025 Letter to Stockholders?
How long will Harrow's Q2 2025 earnings webcast replay be available?
